Skip to main content

Table 4 Severity of ADEs based on the modified Hartwig ADEs Severity Assessment Scale, WSUTRH, February 2021 to July 2021

From: Incidence of adverse drug events in patients hospitalized in the medical wards of a teaching referral hospital in Ethiopia: a prospective observational study

Levela

Description

Frequency

%

1

An ADE occurred but required no change in treatment with the suspected drug

15

23.4

2

The ADE required that treatment with the suspected drug be held, discontinued, or otherwise changed. No antidote or other treatment requirement was required. No increase in hospital stays.

13

20.3

3

The ADE required that treatment with the suspected drug be held, discontinued, or otherwise changed AND/OR an antidote or another treatment was required. No increase in hospital stays.

23

35.9

4

Any Level 3 ADE which increases the length of stay by at least 1 day.

12

18.7

5

Any level 4 ADE which requires intensive medical care.

0

0

6

The ADE caused permanent harm to the patient

1

1.6

7

The ADE which led to the death of the patient

0

0

Total

64

100

  1. a1&2 = mild, 3&4 = moderate, 5–7 = severe
  2. ADES Adverse drug events, WSUTRH Wolaita Sodo University teaching referral hospital